GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PolyPeptide Group AG (XSWX:PPGN) » Definitions » Ending Cash Position

PolyPeptide Group AG (XSWX:PPGN) Ending Cash Position : CHF90.3 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is PolyPeptide Group AG Ending Cash Position?

PolyPeptide Group AG's Ending Cash Position for the quarter that ended in Dec. 2023 was CHF90.3 Mil.

PolyPeptide Group AG's quarterly Ending Cash Position declined from Dec. 2022 (CHF37.0 Mil) to Jun. 2023 (CHF8.8 Mil) but then increased from Jun. 2023 (CHF8.8 Mil) to Dec. 2023 (CHF90.3 Mil).

PolyPeptide Group AG's annual Ending Cash Position declined from Dec. 2021 (CHF141.8 Mil) to Dec. 2022 (CHF37.0 Mil) but then increased from Dec. 2022 (CHF37.0 Mil) to Dec. 2023 (CHF90.3 Mil).


PolyPeptide Group AG Ending Cash Position Historical Data

The historical data trend for PolyPeptide Group AG's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PolyPeptide Group AG Ending Cash Position Chart

PolyPeptide Group AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial 19.12 18.60 141.85 37.04 90.26

PolyPeptide Group AG Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only 141.85 68.14 37.04 8.77 90.26

PolyPeptide Group AG Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

PolyPeptide Group AG's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=35.392+54.866
=90.3

PolyPeptide Group AG's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=8.473+81.785
=90.3


PolyPeptide Group AG Ending Cash Position Related Terms

Thank you for viewing the detailed overview of PolyPeptide Group AG's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


PolyPeptide Group AG (XSWX:PPGN) Business Description

Traded in Other Exchanges
Address
Neuhofstrasse 24, Baar, Zug, CHE, 6340
PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives a majority of its revenue from Europe and Asia.

PolyPeptide Group AG (XSWX:PPGN) Headlines

No Headlines